Form D · Pharmaceuticals
Praxis Precision Medicines, Inc.
Cambridge, MA · CIK 0001689548
Offering snapshot reported Jun 27, 2019 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 18, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 27, 2019 | Initial | $9,999,998 | No comparison | 5 | SEC filing |
| Mar 26, 2018 | Initial | $18,785,901 | No comparison | 6 | SEC filing |
| Nov 10, 2016 | Initial | $3,081,849 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-342943
Source: Form D, filed Jun 27, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ari Brettman | Director |
| Stuart Chaffee | Executive |
| Thomas Dyrberg | Director |
| Nicholas Galakatos | Director |
| Paul Medeiros | Director |
| Gregory Norden | Director |
| Kiran Reddy | Director, Executive |
| Alfred Sandrock | Director |
| Alfred Sandrock, Jr. | Director |
| Stefan Vitorovic | Director |
| William Young | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One Broadway, 16 Th Floor
Cambridge, MA, 02142
Cambridge, MA, 02142